300 results on '"Hoermann, Rudolf"'
Search Results
2. Population data evidence of interdependence of the limbs of hormonal feedback loops
3. Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): design and implementation of an open-label randomised trial
4. Continuous home terlipressin infusion increases handgrip strength and reduces ascites—A prospective randomized crossover study
5. Effect of Radioiodine Treatment on Quality of Life in Patients with Subclinical Hyperthyroidism: A Prospective Controlled Study
6. Cardiometabolic Effects of Denosumab in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression: RCT
7. Changes in white adipose tissue gene expression in a randomized control trial of dieting obese men with lowered serum testosterone alone or in combination with testosterone treatment
8. Branched‐chain amino acid supplementation does not improve measures of sarcopenia in cirrhosis: results of a randomised controlled trial.
9. Re Thyroid Stimulating Hormone and Thyroid Hormones (Triiodothyronine and Thyroxine): An American Thyroid Association-Commissioned Review of Current Clinical and Laboratory Status.
10. A body shape index (ABSI) reflects body composition changes in response to testosterone treatment in obese men
11. Effects of aromatase inhibitor therapy on adiposity and cardiometabolic health in postmenopausal women: a controlled cohort extension study
12. Comment on “Levothyrox® New and Old Formulations: Are They Switchable for Millions of Patients?”
13. The role of supporting and disruptive mechanisms of FT3 homeostasis in regulating the hypothalamic–pituitary–thyroid axis
14. sj-docx-1-tae-10.1177_20420188231158163 – Supplemental material for The role of supporting and disruptive mechanisms of FT3 homeostasis in regulating the hypothalamic–pituitary–thyroid axis
15. Time for a reassessment of the treatment of hypothyroidism
16. Modeling Supportive and Disruptive Mechanisms of FT3 Homeostasis: Supplementary Information
17. Effects of oestradiol treatment on hot flushes in men undergoing androgen deprivation therapy for prostate cancer: a randomised placebo-controlled trial
18. Physiological linkage of thyroid and pituitary sensitivities
19. Effects of androgen deprivation therapy on telomere length
20. The effects of testosterone on body composition in obese men are not sustained after cessation of testosterone treatment
21. Effect of testosterone treatment on bone remodelling markers and mineral density in obese dieting men in a randomized clinical trial
22. Minimal HPT Axis Model: Supplementary Information
23. Effects of estradiol on bone in men undergoing androgen deprivation therapy: a randomized placebo-controlled trial
24. Reduced upper limb lean mass on dual energy X-ray absorptiometry predicts adverse outcomes in male liver transplant recipients
25. Principles of Endocrine Regulation: Reconciling Tensions Between Robustness in Performance and Adaptation to Change
26. Additional file 4 of Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): design and implementation of an open-label randomised trial
27. Additional file 1 of Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): design and implementation of an open-label randomised trial
28. Additional file 2 of Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): design and implementation of an open-label randomised trial
29. Additional file 3 of Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): design and implementation of an open-label randomised trial
30. Quality of life decrements in men with prostate cancer undergoing androgen deprivation therapy
31. Androgen deprivation causes selective deficits in the biomechanical leg muscle function of men during walking: a prospective case–control study
32. Effects of aromatase inhibitor therapy on visceral adipose tissue area and cardiometabolic health in postmenopausal women with early and locally advanced breast cancer.
33. Effect of estradiol on cognition in men undergoing androgen deprivation therapy: A randomized placebo‐controlled trial
34. Effects of estradiol on fat in men undergoing androgen deprivation therapy: a randomized trial
35. Low testosterone as a better predictor of mortality than sarcopenia in men with advanced liver disease
36. Effect of testosterone treatment on cardiac biomarkers in a randomized controlled trial of men with type 2 diabetes
37. Treatment options for subclinical hypothyroidism
38. Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: a systematic review and meta-analysis of randomized controlled clinical trials
39. Sex steroids levels in chronic kidney disease and kidney transplant recipients: associations with disease severity and prediction of mortality
40. Response to Comment on Gianatti et al. Effect of Testosterone Treatment on Glucose Metabolism in Men With Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2014;37: 2098–2107
41. Homeostatic equilibria between free thyroid hormones and pituitary thyrotropin are modulated by various influences including age, body mass index and treatment
42. Effect of Testosterone Treatment on Constitutional and Sexual Symptoms in Men With Type 2 Diabetes in a Randomized, Placebo-Controlled Clinical Trial
43. The two faces of Janus
44. Re: "Thyroid Stimulating Hormone and Thyroid Hormones (Triiodothyronine and Thyroxine): An American Thyroid Association-Commissioned Review of Current Clinical and Laboratory Status" by Van Uytfanghe et al.
45. Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: A 2-Year RCT
46. Zoledronic acid does not affect insulin resistance in men receiving androgen deprivation therapy: a prespecified secondary analysis of a randomised controlled trial
47. Letter to the Editor:Hoermann Response to Fitzgeraldet al. (DOI: 10.1089/thy.2019.0535)
48. The Two Faces of Janus: Why Thyrotropin as a Cardiovascular Risk Factor May Be an Ambiguous Target
49. Who is afraid of non-normal data? Choosing between parametric and non-parametric tests: a response
50. Differing Effects of Zoledronic Acid on Bone Microarchitecture and Bone Mineral Density in Men Receiving Androgen Deprivation Therapy: A Randomized Controlled Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.